S

Solventum

Global healthcare company: wound care, dental

Business Resilience Manager

Full-TimePosted on 10/20/2026
$163.2k - $224.4k
Expert
Bachelor's
Remote in USA
RemoteWork must be performed within the United States; work in unincorporated areas of Los Angeles County is excluded.
Risk & Compliance
No H1B Sponsorship

About the job

Requirements
  • A Bachelor’s degree or higher and 10 years of experience in business resilience, disaster recovery, crisis management, risk management, or a related field in a private, public, government, or military environment; alternatively, a high school diploma or GED and 14 years of experience in those fields.
  • Professional certification in business continuity and/or emergency management, such as CBCI, CBCP, or MBCI, either current or previously held.
  • Experience with ISO 22301.
Responsibilities
  • Lead development, implementation, and continuous improvement of the enterprise Business Resilience program, including governance, methodologies, standards, tools, and assurance activities.
  • Coordinate Business Resilience with Crisis Management, Technology Resilience, Cybersecurity Incident Response, Manufacturing and Operational Technology resilience, Supply Chain, Enterprise Risk Management, and related disciplines.
  • Align business-defined recovery requirements, technology recovery capabilities, operational dependencies, and crisis decision-making processes.
  • Lead enterprise Business Impact Analysis and continuity-planning cycles; establish minimum program and plan requirements; maintain an integrated view of critical business services and dependencies; oversee exercises and corrective-action management.
  • Support delivery of Internal Audit and management remediation commitments related to business resilience.
  • Operationalize the Business Resilience governance framework and develop and maintain the BCM operating model, program charter, policies, procedures, methodologies, standards, and annual program plan.
  • Identify and implement opportunities to use artificial intelligence and automation to strengthen business resilience capabilities, including risk identification, scenario analysis, business impact analysis, and crisis preparedness and response.
  • Serve as principal program lead for the BCM system and associated program data.
  • Translate Internal Audit, regulatory, and management findings into structured remediation plans with defined owners, milestones, dependencies, evidence requirements, and target outcomes.
  • Monitor remediation progress, challenge delays or gaps, escalate material risks, and prepare regular status updates for program and executive governance bodies.
  • Design and facilitate discussion-based and operational exercises that test governance, plans, recovery strategies, communication methods, dependencies, and decision-making.
  • Establish an exception-management process for business areas unable to meet BCM standards or documented recovery requirements.
  • Maintain evidence supporting program implementation, control operation, management oversight, and remediation closure.
  • Establish an after-action process that captures observations, root causes, accountable corrective actions, target dates, validation evidence, and closure approval.
  • Analyze exercise and incident results to identify recurring or enterprise-wide weaknesses.
  • Develop executive dashboards covering BIA coverage, plan quality, exercising, recovery capability gaps, overdue actions, exceptions, and remediation performance.
  • Prepare program reports identifying trends, systemic risks, decisions required, and areas requiring leadership intervention.
  • Create guidance, templates, toolkits, and communications to help business teams meet BCM requirements consistently.
  • Champion responsible adoption of AI-enabled tools and emerging technologies to improve resilience insights, accelerate decision-making, and enhance program efficiency and effectiveness.
  • Represent the BCM program in governance forums, audits, assessments, major projects, and risk discussions.
  • Own and continuously improve the enterprise BIA and continuity-risk assessment methodology.
  • Lead the enterprise BIA cycle and ensure coverage of critical business services, processes, products, locations, and supporting operations.
  • Establish criteria for assessing operational, customer, patient, financial, regulatory, legal, reputational, and strategic impacts.
  • Guide business leaders and process owners in establishing recovery time objectives, recovery point objectives, impact tolerances, minimum resource requirements, and recovery priorities.
  • Maintain an enterprise inventory of dependencies, including people, technology, data, facilities, suppliers, operational technology, equipment, utilities, logistics, and interdependent processes.
  • Analyze BIA results to identify risk concentrations, single points of failure, conflicting recovery requirements, and systemic dependencies.
  • Align business-defined recovery requirements with Technology Resilience application tiering, IT contingency planning, recovery strategies, and testing priorities.
  • Escalate material gaps between required recovery outcomes and demonstrated recovery capabilities.
  • Support maintenance and improvement of the Crisis Management Framework, including escalation criteria, team structures, roles, decision rights, communication protocols, activation procedures, and supporting playbooks.
  • Ensure the Crisis Management Framework is integrated with the Business Resilience program and aligned with business continuity and technology recovery arrangements.
  • Provide specialist advice during crisis activations and significant disruptions.
  • Support or coordinate situation reporting, action tracking, decision logging, stakeholder briefings, response documentation, and transition-to-recovery activities.
  • Support post-incident reviews and ensure lessons learned are translated into sustainable corrective actions.
Desired Qualifications
  • Familiarity with relevant standards, regulations, and frameworks, including ISO 22317, ISO 22361, NIST SP 800-34, NFPA 1600, and ASIS Business Continuity and Crisis Management Standards.
  • Experience conducting business impact analyses and developing business continuity plans.
  • Previous manufacturing experience.
  • Working knowledge of risk assessment techniques, BIA methodology, and recovery strategy development.
  • Ability to analyze data and interviews and produce clear findings and recommendations.
  • Planning, organizational, and project management skills, including the ability to manage multiple concurrent workstreams to target dates.
  • Proficiency with business continuity software platforms such as ServiceNow BCM and emergency notification systems such as Horizon or Everbridge.
  • Knowledge of IT infrastructure, application recovery, and data protection principles sufficient to partner effectively with IT disaster recovery teams.

About the company

Solventum provides a wide range of healthcare products across four main areas: wound care and surgical supplies, dental and orthodontic tools, health information software, and purification filters for biopharmaceuticals. These products work by combining material science and data science to help hospitals manage patient records, prevent infections during surgery, and filter fluids for medical treatments like dialysis. Unlike many competitors, the company holds a massive portfolio of over 7,300 patents inherited from its history as a 3M division, allowing it to serve over 75% of U.S. hospitals. Its goal is to use this intellectual property and a disciplined business model to find new solutions for healthcare providers and grow within the global medical technology market.

Company Size

10,001+

Company Stage

IPO

Headquarters

Eagan, Minnesota

Founded

2023

Get referred to Solventum

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 organic sales rose 9.5%, and management raised EPS guidance to $7.10-$7.20.
  • Solventum announced HIS separation on August 5, 2026, sharpening its MedTech focus.
  • The $200 million Eagan Innovation Hub supports roughly 20 launches over two years.

What critics are saying

  • Management expects HIS separation to cut margins about 400 basis points after offsets.
  • ERP cutover orders distorted Q2 2026; Q3 growth resets when demand normalizes.
  • Legal costs, restructuring, and separation complexity keep Solventum exposed until 2027-2028 transactions close.

What makes Solventum unique

  • Solventum combines MedSurg, Dental, and clinical workflow assets from 3M’s healthcare spinout.
  • Its 2026 Eagan Innovation Hub concentrates wound care, sterilization, and digital health R&D.
  • The company still sells into over 75% of U.S. hospitals through entrenched workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Health Savings Account/Flexible Spending Account
  • Remote Work Options
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

6 month growth

6%

1 year growth

5%

2 year growth

9%
PR Newswire
Oct 19th, 2026
Solventum wins FDA clearance to combine Restrata Matrix with V.A.C. Therapy for wound healing

Solventum has received US Food and Drug Administration (FDA) 510(k) clearance to use Restrata Synthetic Electrospun Fiber Matrix together with its V.A.C. Therapy, the company announced on October 19, 2026. The clearance follows Solventum's acquisition of Acera Surgical in December 2025. Restrata is a fully synthetic, resorbable matrix that supports soft tissue repair, while V.A.C. Therapy applies negative pressure to promote wound healing. Solventum says the matrix resists enzymatic degradation and matches the dressing's wear time of up to seven days. Many collagen-based dressings degrade too early for such use. The pairing may mean fewer dressing changes and a more predictable workflow for care teams. "We're giving clinicians an effective way to streamline care and support better patient outcomes," said Kelley Moffett, president of Advanced Wound Care at Solventum.

Yahoo Finance
Aug 20th, 2026
BrightSpring Health Services posts 23.9% revenue growth as Solventum and Inspire Medical face headwinds

BrightSpring Health Services stands out as a strong long-term healthcare investment, whilst Solventum and Inspire Medical Systems face headwinds, according to recent analysis. Healthcare stocks have surged 27.5% over the past six months, outperforming the S&P 500 by 16.2 percentage points. However, increased venture capital has intensified competition across the sector. BrightSpring, which provides home health care, hospice, and pharmacy services, has achieved 23.9% annual revenue growth over the past two years. Analysts forecast 14.1% revenue growth for the next 12 months. Conversely, Solventum faces weak demand with flat revenue expected, whilst its free cash flow margin has declined 18.2 percentage points over five years. Inspire Medical Systems confronts a forecasted revenue decline of 3.5% for the upcoming year.

Yahoo Finance
Aug 11th, 2026
Solventum beats Q2 estimates with $2.21B revenue, raises EPS guidance 10% amid HIS separation

Healthcare solutions provider Solventum reported second quarter revenue of $2.21 billion, up 2.2% year on year and ahead of analyst estimates of $2.15 billion. Non-GAAP profit of $2.55 per share beat consensus estimates by 33.8%. The company announced plans to separate its Health Information Systems business to focus on its MedSurg and Dental segments. Management said the move would allow the HIS unit to pursue AI-driven innovation whilst sharpening Solventum's focus as a pure-play MedTech company. Second quarter results were temporarily boosted by approximately $125 million in advanced orders placed ahead of a major ERP system transition, which management expects to reverse next quarter. The company raised its full-year adjusted EPS guidance to $7.15 at the midpoint, a 10% increase. Solventum is nearing completion of its separation from 3M.

Yahoo Finance
Aug 9th, 2026
Solventum raises 2026 outlook with 9.5% Q2 growth boosted by $125M advanced orders and $100M tariff refund

Solventum exceeded expectations in Q2, posting $2.2 billion in sales with 9.5% organic growth. However, this included roughly $125 million in advanced ERP-related orders and a $100 million tariff refund. Excluding these benefits, organic growth was approximately 4% and adjusted EPS was estimated at $1.73. The company raised its 2026 outlook, now expecting 2.5%–3% organic sales growth, a 22.2%–22.7% operating margin, adjusted EPS of $7.10–$7.20, and free cash flow of $200 million–$300 million. Third-quarter growth is expected to decline temporarily as the advanced orders reverse. Solventum also announced plans to separate its Health Information Systems business through a potential spin-off or sale, aiming to focus on its MedSurg and Dental segments.

PR Newswire
Aug 5th, 2026
Solventum Q2 sales up 9.5%, raises 2026 guidance and plans to separate Health Information Systems unit

Solventum reported second quarter 2026 sales of $2.2 billion, up 2.2% on a reported basis and 9.5% organically. The MedTech company posted GAAP diluted earnings per share of $0.53 and adjusted diluted EPS of $2.55, marking a 50.9% increase. Operating cash flow reached $227 million, whilst free cash flow totalled $144 million. The strong performance was driven by volume and product mix across all segments, including advance orders ahead of ERP cutovers. Solventum announced plans to separate its Health Information Systems business segment as part of its transformation strategy. The company raised its full-year 2026 guidance, increasing organic sales growth to 2.5% to 3.0%, adjusted EPS to $7.10 to $7.20, and free cash flow to $200 million to $300 million.